Weight loss can change the severity of obstructive sleep apnea. The evidence for tirzepatide for sleep apnea comes from trials in adults with obesity. A separate survey asked how sleep clinics follow up [1].
What the sleep centers reported
The survey covered sleep centers in 14 European countries (n = 24). Sixty-one percent considered weight loss above 10% meaningful for reassessment. Fourteen percent proactively retitrated or withdrew positive airway pressure therapy. The survey measured what centers reported. It did not track patient outcomes.
The survey also asked about diagnostic testing after medication started [1]. Ninety-two percent of respondents recommended sleep studies for symptomatic patients. For asymptomatic patients, the reported figure was 81%. These questions included people with suspected or established sleep apnea. They do not measure routine follow-up testing for people already using CPAP.
When to ask about reassessment
A sleep clinician can decide if repeat testing would change your care. The distinction between treating sleep apnea and preventing it matters when interpreting these studies. A lower weight alone cannot show that airway pressure therapy is unnecessary.
US sleep medicine guidance allows repeat testing after clinically significant weight change [2]. It also allows testing if symptoms persist or return despite regular use. Ask your sleep clinician about follow-up if your weight or symptoms change. Keep using CPAP as prescribed while you seek advice.